About JSP Pharma
JSP Pharmaceutical Manufacturing (Thailand) PCL., are strong in the business of OEM manufacturing service of Supplement, Pharmaceutical, Herbal and Cosmetics products.
We are capable to produce several categories of dosage form such as Tablet, Capsule, Soft-gelatin capsule, Powder and our latest new categories; Gummy and Chewable soft-gelatin capsule. We do OEM services under keyword “ONE STOP SERVICE”. We do R&D, FDA submission, Artwork design and evaluation, production and then, Delivery.
With rather than 40 years of experience in this business, we can be guaranteed by global standard such as GMP, ISO 9001:2015 and PIC/s.
2023
February: The Board of Directors’ Meeting has resolved to approve the establish of a subsidiary i.e. JSP Pharma Holding Company Limited; operates business in investing in other businesses, with initial registered capital of Baht 200,000,000 divided into 2,000,000 shares at a par value of Baht 100 per share which the Company held 99.99% of registered and paid-up capital. The registration of company and paid-up share capital with the Ministry of Commerce have been completed in August 2023.
April: The Extraordinary General Meeting of Shareholders had the resolutions in significant matters as follows:
1) Invested in the academic laboratory research, scientific test and analysis, training and seminar, and consultancy for research fund application businesses of CDIP (Thailand) Public Co., Ltd. by the Company’s newly established subsidiary company, with the consideration in cash not exceeding Baht 200,000,000.
2) Entered into connected transaction and acquisition of ordinary shares of CDIP (Thailand) Public Co., Ltd. by the Company’s subsidiary. The Company’s subsidiary will acquire 156,000,000 ordinary shares, equivalent to 65.00% of registered and paid-up capital from Daengpraset family, which is the Company’s major shareholder.
May: The Company acquired 21,118 ordinary shares of Grace Water Med Company Limited, which equivalent to 52.80% of registered and paid-up capital with consideration of Baht 43,900,000. Grace Water Med Company operates business in manufacturing and distributing of hemodialysis solution and related medical supplies.
August: JSP Pharma Holding Company Limited has completed acquisition of CDIP (Thailand) Public Co., Ltd. which was considered as business combination under common control since Daengprasert family is ultimate major shareholder pre and post transaction
2022
June: The Board of Directors’ Meeting has resolved to approve the establish of a subsidiary i.e. Caresutic Co., Ltd.; operates business in relation to Innovation Center and small-scaled production factory of dietary supplements and cosmetics, with initial registered capital of Baht 5,000,000 divided into 50,000 shares at a par value of Baht 100 per share which the Company held 99.99% of registered and paid-up capital.
August: The Extraordinary General Meeting of Shareholders had the resolutions in significant matters as follows:
1) Changed utilisation objectives of the increase capital from IPO by adding objective about investing in a subsidiary in relation to Innovation Center and small-scaled production factory of dietary supplements and cosmetics and expand business in form of invest in other entities with potential to support and/or enhance the business.
2) Issued the Warrants to Purchase Newly Issued Ordinary Shares of the Company No. 1 not exceeding 227,500,000 units for allotting to the existing shareholders in proportion of their respective shareholding with free-of-charge. The allotment ratio is 2 existing shares to 1 unit of the warrant. The warrant has 2-year maturity and exercise ratio at 1 unit of the warrant to 1 newly issued ordinary shares with Baht 2.50 exercise price.
3) Increased the Company’s registered capital not exceeding Baht 113,750,000 from previously Baht 227,500,000 divided into 455,000,000 shares at a par value of Baht 0.50 per share, to Baht 341,250,000 divided into 682,500,000 shares at a par value of Baht 0.50 per share, by issuing 227,500,000 new ordinary shares at a par value of Baht 0.50 per share in order to support the exercise of the warrants to purchase newly issued ordinary shares of the Company No. 1.
September: The Company has changed security symbol from “JP” to “JSP”
September: Caresutic Co., Ltd; which is the Company’s subsidiary, increased its registered capital amounting to Baht 25,000,000 from previously Baht 5,000,000 divided into 50,000 shares at a par value of Baht 100 per share, to Baht 30,000,000 divided into 300,000 shares at a par value of Baht 100 per share, by issuing 250,000 new ordinary shares at a par value of Baht 100 per share and allotted newly ordinary shares to the Company wholly. Therefore, the Company’s ownership interest in the subsidiary did not change.
December: The Company has finished expanding conventional medicine production line at Bangkok. The new production line could produce conventional medicine totalled 20 – 25 million bottles per year.
2021
May: The Extraordinary General Meeting of Shareholders has resolved to approve the plan to list the company on the Market for Alternative Investment (mai) with the following resolutions:
1) Approved the registered capital increase from Baht 170,000,000 divided into 340,000,000 shares at a par value of Baht 0.50 per share, to Baht 227,500,000 divided into 455,000,000 shares at a par value of Baht 0.50 per share, by issuing 115,000,000 new ordinary shares at a par value of Baht 0.50 per share, totalling Baht 57,500,000 for Initial Public Offering.
2) Approved the allotment of the Company’s newly issued ordinary shares in the amount of 115,000,000 shares at a par value of Baht 0.50 for the Initial Public Offering (IPO) or equivalent to 25.27% of the total paid-up capital post-IPO.
November: Ordinary shares of JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. has been traded in the Market of Alternative Investment (mai) since 2 November 2021.
2018
The Extraordinary General Meeting of Shareholders had the resolution to convert the Company into a Public Company Limited i.e. JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
2017
The Company has been restructured by acquiring COX Laboratories (Thailand) Limited Partnership in which it was considered as business combination under common control since Daengprasert family is ultimate major shareholder pre and post transaction.
2011
Started constructung another new plant at 260 Moo.4 Sri Bua Ban Sub-District, Mueang Lamphun District Lamphun 51000 used in the production of dietary supplements and herbal products.
2005
On 15 November 2005, JSP Pharmaceutical Manufactory (Thailand) Company Limited has been established and registered, with initial registered capital of Baht 1,000,000 divided into 10,000 ordinary shares at a par value of Baht 100 per share. The head office is located at 255,257, Soi Sathupradit 58, Bangphongphang Sub-district, Yannawa District, Bangkok 10120.